FBXW10: A promising drug target and biomarker for the treatment of neurodegenerative diseases

Target Name: FBXW10

NCBI ID: G10517

FBXW10: A promising drug target and biomarker for the treatment of neurodegenerative diseases

FBXW10, a 10kDa protein, has been identified as a potential drug target and biomarker for the treatment of neurodegenerative diseases. FBXW10 is a key component of the endoplasmic reticulum (ER), a complex network of protein transport systems that ensures the proper delivery of proteins to their respective functions in the cell. FBXW10 has been shown to localize to the endoplasmic reticulum, where it plays a crucial role in the retrieval and degradation of proteins.

The neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, are characterized by the progressive loss of brain cells and the development of severe cognitive and motor impairments. These conditions are associated with the accumulation of misfolded proteins, including those involved in the ER-associated degradation (ERAD) pathway. Therefore, targeting the ER-associated degradation pathway, as well as the regulation of endoplasmic reticulum-associated protein (ERAP), is a promising strategy for the development of new neurodegenerative disease therapies.

FBXW10 as a drug target

The FBXW10 protein has been shown to play a crucial role in the ER-associated degradation pathway, specifically in the retrieval of misfolded proteins to the ER. In misfolded proteins, the formation of an accordion-like structure in the cytosol, called a exocytosis-endoplasmic retention (ER-ER) domain, is a hallmark of protein misfolding. The ER-ER domain is involved in the formation of a crosstalk between the cytosol and the ER, allowing for the retrieval of misfolded proteins to the ER.

Several studies have demonstrated that FBXW10 is involved in the ER-associated degradation pathway, specifically in the retrieval of misfolded proteins. For instance, one study published in the journal Nature showed that mice lacking the FBXW10 gene had increased levels of misfolded proteins in the ER, compared to wild-type (WT) mice. Additionally, another study published in the journal Biochemical and Cellular Biology found that the FBXW10 protein was specifically localized to the ER in rat brain, and that it was involved in the retrieval of misfolded proteins to the ER.

FBXW10 as a biomarker

FBXW10 has also been shown to serve as a potential biomarker for the assessment of neurodegenerative diseases. The ER-associated degradation pathway is a known risk factor for the development of neurodegenerative diseases, and alterations in the ER-associated degradation pathway have been observed in various neurodegenerative diseases. Therefore, the detection of changes in the ER-associated degradation pathway, including changes in the FBXW10 protein, could be a valuable diagnostic or therapeutic target.

Studies have shown that changes in the ER-associated degradation pathway, as well as the FBXW10 protein, are associated with the development of neurodegenerative diseases. For instance, one study published in the journal Alzheimer's Disease found that individuals with Alzheimer's disease had lower levels of FBXW10 in the brain compared to healthy individuals. Additionally, another study published in the journal Parkinson's Disease found that individuals with Parkinson's disease had increased levels of misfolded proteins in the brain, which were similar to those observed in individuals with Alzheimer's disease.

In conclusion, FBXW10 is a protein that has been identified as a potential drug target and biomarker for the treatment of neurodegenerative diseases. The ER-associated degradation pathway, as well as

Protein Name: F-box And WD Repeat Domain Containing 10

Functions: Probable substrate-recognition component of a SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Overexpression is leading to degradation of CBX5 and CBX1

More Common Targets